Mary Stahley

Mary Stahley is the Director, Process Development at Verve Therapeutics with expertise in nucleic acid and nucleic acid enzyme biophysics. Prior to joining Verve, she was a development scientist at Alexion Pharmaceuticals for six years. Dr. Stahley holds a B.A. in biophysics from Johns Hopkins University.

She received her Ph.D. in molecular biophysics and biochemistry at Yale University and completed her postdoctoral research in the pharmacology and molecular sciences department at Johns Hopkins Medical School.